KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Guardant Health (GH) over the last 1 years, with Q3 2025 value amounting to $45.0 million.

  • Guardant Health's Treasury Shares fell 8033.76% to $976351.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $976351.0, marking a year-over-year decrease of 8033.76%. This contributed to the annual value of $7.0 million for FY2024, which is 6150.44% up from last year.
  • Latest data reveals that Guardant Health reported Treasury Shares of $976351.0 as of Q3 2025, which was down 8033.76% from $976351.0 recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Treasury Shares ranged from a high of $7.0 million in Q4 2024 and a low of $976351.0 during Q1 2025
  • Moreover, its 5-year median value for Treasury Shares was $2.8 million (2022), whereas its average is $3.1 million.
  • As far as peak fluctuations go, Guardant Health's Treasury Shares surged by 36239.86% in 2021, and later plummeted by 8135.58% in 2025.
  • Quarter analysis of 5 years shows Guardant Health's Treasury Shares stood at $1.5 million in 2021, then skyrocketed by 146.1% to $3.7 million in 2022, then increased by 17.87% to $4.3 million in 2023, then soared by 61.5% to $7.0 million in 2024, then tumbled by 86.09% to $976351.0 in 2025.
  • Its last three reported values are $45.0 million in Q3 2025, $45.0 million for Q2 2025, and $45.0 million during Q1 2025.